550
Views
3
CrossRef citations to date
0
Altmetric
Clinical Dilemma

Novel agents versus chemotherapy as frontline treatment of CLL

, &
Pages 1320-1324 | Received 27 Dec 2016, Accepted 04 Jan 2017, Published online: 06 Feb 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ayed O. Ayed & Sameer A. Parikh. (2018) Management of patients with chronic lymphocytic leukemia at high risk of relapse on ibrutinib therapy. Leukemia & Lymphoma 59:10, pages 2287-2296.
Read now

Articles from other publishers (2)

Małgorzata Kubczak, Aleksandra Szustka, Jerzy Błoński, Tomaš Guck�, Małgorzata Misiewicz, Vladmir Krystof, Paweł Robak & Małgorzata Rogalińska. (2019) Dose and drug changes in chronic lymphocytic leukemia cell response in�vitro: A comparison of standard therapy regimens with two novel cyclin‑dependent kinase inhibitors. Molecular Medicine Reports.
Crossref
Cécile Conte, Aurore Palmaro, Pascale Grosclaude, Laetitia Daubisse-Marliac, Fabien Despas & Maryse Lapeyre-Mestre. (2018) A novel approach for medical research on lymphomas. Medicine 97:2, pages e9418.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.